Document is current
Any future updates will be listed below
-
Authors
Noortman, Wyanne A. https://orcid.org/0000-0003-0450-951X
Vriens, Dennis
Bussink, Johan
Meijer, Tineke W. H.
Aarntzen, Erik H. J. G.
Deroose, Christophe M.
Lhommel, Renaud
Aide, Nicolas
Le Tourneau, Christophe
de Koster, Elizabeth J.
Oyen, Wim J. G.
Triemstra, Lianne
Ruurda, Jelle P.
Vegt, Erik
de Geus-Oei, Lioe-Fee
van Velden, Floris H. P.
- License Information
-
More Information
Article History
Received: 18 October 2024
Revised: 2 April 2025
Accepted: 7 April 2025
First Online: 7 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Floris H.P. van Velden.
: The authors of this manuscript declare relationships with the following companies: Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO, Immedica Pharma, Molecular Partners, Nuclear Research and Consultancy, and GE Healthcare. D.V. is a member of the Scientific Editorial Board of European Radiology (section: Nuclear Medicine and Molecular Imaging). As such, they did not participate in the selection or review processes for this article.
: One of the authors has significant statistical expertise.
: In all but the PPGL cohort, patients signed an informed consent form. In the PPGL cohort, informed consent was waived by the Institutional Review Board due to the retrospective nature of the study and patients who objected to the use of their anonymised data were excluded.
: Institutional Review Board approval was obtained in all five cohorts.
: Some study subjects have been previously reported in refs. [–, ].
:
